PH30346A - Benzopyran and related ltb4 antagonists - Google Patents

Benzopyran and related ltb4 antagonists

Info

Publication number
PH30346A
PH30346A PH45558DA PH30346A PH 30346 A PH30346 A PH 30346A PH 45558D A PH45558D A PH 45558DA PH 30346 A PH30346 A PH 30346A
Authority
PH
Philippines
Prior art keywords
benzopyran
ltb4 antagonists
related ltb4
antagonists
ltb4
Prior art date
Application number
Other languages
English (en)
Inventor
Kevin Koch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH30346A publication Critical patent/PH30346A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
PH45558D 1992-01-23 1993-01-13 Benzopyran and related ltb4 antagonists PH30346A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82441292A 1992-01-23 1992-01-23

Publications (1)

Publication Number Publication Date
PH30346A true PH30346A (en) 1997-04-02

Family

ID=25241346

Family Applications (1)

Application Number Title Priority Date Filing Date
PH45558D PH30346A (en) 1992-01-23 1993-01-13 Benzopyran and related ltb4 antagonists

Country Status (37)

Country Link
US (2) US5552435A (fr)
EP (1) EP0623123B1 (fr)
JP (1) JP2765757B2 (fr)
KR (2) KR0124802B1 (fr)
CN (1) CN1041311C (fr)
AP (1) AP352A (fr)
AT (1) ATE152108T1 (fr)
AU (1) AU666896B2 (fr)
BG (1) BG62331B1 (fr)
BR (1) BR9207061A (fr)
CA (1) CA2126752C (fr)
CZ (1) CZ282400B6 (fr)
DE (1) DE69219364T2 (fr)
DK (1) DK0623123T3 (fr)
EG (1) EG20202A (fr)
FI (1) FI943474A (fr)
GR (1) GR3023657T3 (fr)
HK (1) HK1000245A1 (fr)
HU (1) HU221194B1 (fr)
IL (1) IL104386A (fr)
IS (1) IS1795B (fr)
MX (1) MX9300312A (fr)
MY (1) MY109144A (fr)
NO (1) NO306508B1 (fr)
NZ (1) NZ245735A (fr)
OA (1) OA11456A (fr)
PH (1) PH30346A (fr)
PL (1) PL171003B1 (fr)
PT (1) PT101183B (fr)
RO (1) RO112031B1 (fr)
RU (1) RU2114110C1 (fr)
SG (1) SG49813A1 (fr)
SK (1) SK280451B6 (fr)
TW (1) TW213907B (fr)
WO (1) WO1993015067A1 (fr)
YU (1) YU48949B (fr)
ZA (1) ZA93486B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2084547B1 (es) * 1993-07-12 1997-01-16 Pfizer Antagonistas benzopiranicos y relacionados de leucotrieno b4.
MX9702731A (es) * 1994-10-13 1997-06-28 Pfizer Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos.
CA2202056A1 (fr) * 1994-10-13 1996-04-25 Mark A. Dombroski Composes de benzopyranne et composes benzo-fusionnes, leur preparation et leur utilisation comme antagonistes du leucotriene b4' (ltb4)
SK31399A3 (en) * 1996-09-16 2000-05-16 Pfizer Processes and intermediates for preparing substituted chromanol derivatives
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
EP0836850A3 (fr) * 1996-10-17 2000-11-29 Pfizer Inc. Méthode pour prévenir le rejet d'allogreffes
EP0963755A3 (fr) * 1998-04-16 2001-03-14 Pfizer Products Inc. Utilisation des benzopyranes pour la prévention de rejets de graiffes
US6436987B1 (en) * 2000-06-08 2002-08-20 Pfizer Inc. Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid
JP2004512382A (ja) 2000-11-03 2004-04-22 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー 心臓灌流および心臓炎症の2核種同時イメージング
CA2433516A1 (fr) * 2001-01-30 2002-08-08 Keith Michael Devries Procedes de preparation d'acides chromanylbenzoiques
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
CA2574627A1 (fr) * 2004-07-22 2006-02-02 Pharmacia Corporation Compositions pour le traitement anti-inflammatoire et anti-douleur au moyen d'une combinaison d'un inhibiteur selectif cox-2 et d'un antagoniste recepteur de ltb<sb>4</sb>
EP3383389B1 (fr) * 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1
US20190382363A1 (en) 2015-11-30 2019-12-19 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
US10336733B2 (en) 2015-11-30 2019-07-02 Merk Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
US10450309B2 (en) 2015-11-30 2019-10-22 Merch Sharp & Dohme Corp. Aryl sulfonamides as BLT1 antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2309282A1 (de) * 1973-02-24 1974-08-29 Hoechst Ag Verfahren zur herstellung von 4-hydroxy-thiochromanen
DE2745305A1 (de) * 1977-10-07 1979-04-19 Bayer Ag Insektizide und akarizide mittel
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (fr) * 1987-01-12 1993-07-20 Darrel M. Gapinski Agents antiinflammatoires
JPS63292977A (ja) * 1987-05-25 1988-11-30 片山 晋 スキ−用のビンディング固定板
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
WO1990012010A1 (fr) * 1989-04-07 1990-10-18 Pfizer Inc. Chromans substitues pour le traitement de l'asthme, de l'arthrite et de maladies apparentees
WO1990015801A1 (fr) * 1989-06-22 1990-12-27 Pfizer Inc. Sulfamides substitues et composes apparentes dans le traitement de l'asthme, de l'arthrite et des maladies apparentees
WO1991012253A1 (fr) * 1990-02-07 1991-08-22 Pfizer Inc. Derives de tetraline et de chroman utilises dans le traitement de l'asthme, de l'arthrite et de maladies apparentees
WO1993015066A1 (fr) * 1992-01-23 1993-08-05 Pfizer Inc. Benzopyranne et antagonistes du ltb4 apparentes
HRP930210A2 (en) * 1992-02-25 1995-06-30 Recordati Chem Pharm Heterobicyclic compounds and pharmaceutical preparations containing them
FR2693196B1 (fr) * 1992-07-03 1994-12-23 Lipha Dérivés de benzopyranone ou de benzothiopyranone, procédé de préparation et composition pharmaceutique les contenant.

Also Published As

Publication number Publication date
GR3023657T3 (en) 1997-09-30
YU3393A (sh) 1996-07-24
CZ176294A3 (en) 1995-02-15
FI943474A0 (fi) 1994-07-22
HK1000245A1 (en) 1998-02-13
PT101183A (pt) 1994-03-31
SK280451B6 (sk) 2000-02-14
OA11456A (en) 2003-11-18
NO306508B1 (no) 1999-11-15
US5552435A (en) 1996-09-03
IS1795B (is) 2001-12-18
IL104386A (en) 2001-05-20
NO942759L (no) 1994-07-22
BG62331B1 (bg) 1999-08-31
BG98867A (bg) 1995-03-31
JP2765757B2 (ja) 1998-06-18
SK84494A3 (en) 1995-05-10
PT101183B (pt) 1999-09-30
EP0623123A1 (fr) 1994-11-09
WO1993015067A1 (fr) 1993-08-05
IL104386A0 (en) 1993-05-13
AP352A (en) 1994-08-10
CA2126752A1 (fr) 1993-08-05
CA2126752C (fr) 2000-05-16
KR950700273A (ko) 1995-01-16
US5684046A (en) 1997-11-04
DE69219364T2 (de) 1997-08-07
NZ245735A (en) 1995-04-27
BR9207061A (pt) 1995-12-26
MY109144A (en) 1996-12-31
EG20202A (en) 1997-10-30
TW213907B (fr) 1993-10-01
CZ282400B6 (cs) 1997-07-16
JPH07502536A (ja) 1995-03-16
NO942759D0 (no) 1994-07-22
ZA93486B (en) 1994-07-22
DE69219364D1 (de) 1997-05-28
HUT68790A (en) 1995-07-28
RU2114110C1 (ru) 1998-06-27
RU94035964A (ru) 1997-05-27
MX9300312A (es) 1993-07-31
DK0623123T3 (da) 1997-10-13
HU9401979D0 (en) 1994-09-28
FI943474A (fi) 1994-07-22
CN1041311C (zh) 1998-12-23
YU48949B (sh) 2003-01-31
EP0623123B1 (fr) 1997-04-23
AU3065092A (en) 1993-09-01
RO112031B1 (ro) 1997-04-30
AP9200449A0 (en) 1993-01-31
KR0124802B1 (ko) 1997-11-25
HU221194B1 (en) 2002-08-28
SG49813A1 (en) 1998-06-15
IS3969A (is) 1993-07-24
PL171003B1 (pl) 1997-02-28
ATE152108T1 (de) 1997-05-15
CN1075318A (zh) 1993-08-18
AU666896B2 (en) 1996-02-29

Similar Documents

Publication Publication Date Title
HU9402163D0 (en) Benzopyran and related ltb4 antagonists
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
GR3023258T3 (en) 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
EG20202A (en) Benzopyran and related LTB4 antagonists
IL115528A0 (en) Benzopyran and benzo-fused compounds
HRP931012A2 (en) Fungicidal 2-imidazoline-5-one and 2-imidazoline-5-thione derivatives
HU9303442D0 (en) Jodinated benzoyl-acetats and ketals
ZA93582B (en) Substituted hexahyhdroazephinones and tetrahydrobenzazepinones
PL309361A1 (en) Benzopyran derivatives
EP0505941A3 (en) Peptifluorin and neopeptifluorin
ZA93483B (en) Benzopyrans and related ltb antagonists
ZA899435B (en) Benzopyran and related compounds
IL122653A0 (en) Benzopyrans and their preparation
IE901744L (en) Benzopyran and pyridopyran derivatives
ZA925260B (en) 3-aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone
IL125949A0 (en) Benzopyran and benzo-fused compounds and their preparation
GB9118954D0 (en) Construction components and their uses
ZA947921B (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
PL296873A1 (en) Substituted and heterocyclic phtalides